| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |